Detailed Information on Publication Record
2006
Staphylococcus equorum and Staphylococcus succinus isolated from human clinical specimens
NOVÁKOVÁ, Dana, Ivo SEDLÁČEK, Roman PANTŮČEK, Vlastimil ŠTĚTINA, Pavel ŠVEC et. al.Basic information
Original name
Staphylococcus equorum and Staphylococcus succinus isolated from human clinical specimens
Name in Czech
Charakterizace kmenů Staphylococcus equorum a Staphylococcus succinus izolovaných z klinického materiálu humánního původu
Authors
NOVÁKOVÁ, Dana (203 Czech Republic, belonging to the institution), Ivo SEDLÁČEK (203 Czech Republic, guarantor, belonging to the institution), Roman PANTŮČEK (203 Czech Republic, belonging to the institution), Vlastimil ŠTĚTINA (203 Czech Republic), Pavel ŠVEC (203 Czech Republic, belonging to the institution) and Petr PETRÁŠ (203 Czech Republic)
Edition
Journal of Medical Microbiology, Reading, UK, Society for General Microbiology, 2006, 0022-2615
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10600 1.6 Biological sciences
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.180
RIV identification code
RIV/00216224:14310/06:00015634
Organization unit
Faculty of Science
UT WoS
000237150200008
Keywords in English
Staphylococcus equorum; Staphylococcus succinus; identification; ribotyping; human clinical material
Tags
Tags
International impact, Reviewed
Změněno: 21/12/2017 15:28, Ing. Monika Kuchlei Sieberová
V originále
A polyphasic identification approach was applied to a group of 11 novobiocin-resistant staphylococci isolated from human clinical materials. Phenotypic characteristics obtained by both commercial and conventional tests assigned eight strains as Staphylococcus xylosus and three strains as ambiguous S. xylosus/ Staphylococcus equorum. In contrast to biotyping, ribotyping with EcoRI and HindIII and wholle-cell protein fingerprinting assigned six analysed strains as S. equorum, and five strains as Staphylococcus succinus. Confirmation of the identification was done by partial 16S rRNA gene sequencing and S. equorum isolates were verified by a previously described PCR assay targeting the sodA gene. From the data it has been implied that ribotyping and whole-cell protein analysis can be used to differentiate between the biochemically almost indistinguishable species S.xylosus, S. equorum or S. succinus. The present study confirms what is believed to be first occurrence of S. equorum strains in the relevant human clinical material in the Czech Republic and describes what is believed to be first-ever isolation of S. succinus from human clinical material.
In Czech
neuvedeno
Links
| GA301/02/1505, research and development project |
| ||
| GP204/02/D099, research and development project |
| ||
| MSM0021622416, plan (intention) |
|